Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's metadata was updated to include a new revision tag (v3.6.5) and certain related topics (including Melanoma and MedlinePlus Genetics) as well as the prior revision tag (v3.6.4) were removed.
    Difference
    0.2%
    Check dated 2026-08-10T17:47:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The related topics section now lists Melanoma and MedlinePlus Genetics, providing links to disease- and genetics-related information.
    Difference
    0.2%
    Check dated 2026-08-03T12:20:40.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added to the page. The earlier revision text (v3.6.3) and references to Melanoma and related topics (MedlinePlus Genetics) have been removed.
    Difference
    0.2%
    Check dated 2026-07-27T06:22:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's related topics section now includes Melanoma and a MedlinePlus Genetics link, expanding topic associations for readers. The revision version has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T14:43:36.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.0 to v3.6.2, signaling a newer version of the page. The update is a metadata revision with no impact on the displayed study details.
    Difference
    0.1%
    Check dated 2026-06-28T09:06:45.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page's related topics/MeSH metadata no longer lists Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-06-20T22:15:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.